市場調査レポート

禁煙・脱ニコチン中毒製品の世界市場 2015-2023年 (ニコチンガム、パッチ、トローチ剤、吸入薬、スプレー、舌下錠、ほか) :産業分析、規模、シェア、成長率、動向および予測

Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

発行 Transparency Market Research 商品コード 298295
出版日 ページ情報 英文 82 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
禁煙・脱ニコチン中毒製品の世界市場 2015-2023年 (ニコチンガム、パッチ、トローチ剤、吸入薬、スプレー、舌下錠、ほか) :産業分析、規模、シェア、成長率、動向および予測 Smoking Cessation and Nicotine De-addiction Products Market (Nicotine Gums, Patches, Lozenges, Inhalers, Sprays, Sublingual Tablets, Zyban, Chantix/Champix, E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023
出版日: 2016年01月12日 ページ情報: 英文 82 Pages
概要

禁煙または脱ニコチン中毒は、ニコチン代用製品、電子たばこ (eシガレット) 、Zyban (ブプロピオン) やChantix/Champix (バレニクリン) などの抗うつ薬やニコチン受容体作動薬など、多様な形態によって達成することが可能です。また、禁煙は門医の助けを借りなくても達成可能です。

当レポートでは、世界の禁煙・脱ニコチン中毒製品市場について調査し、市場概要、タイプ・地域別の市場分析と予測、競合情勢の分析、および主要企業のプロファイルなどをまとめ、提供しています。

第1章 序文

第2章 エグゼクティブサマリー

第3章 産業分析:禁煙・脱ニコチン中毒製品市場

  • イントロダクション・市場定義
  • 市場ダイナミクス
    • 促進因子
    • 抑制因子
    • 機会
  • 市場の魅力分析:地域別
  • 競合情勢:ヒートマップ分析

第4章 禁煙・脱ニコチン中毒製品市場区分:タイプ別

  • 世界の禁煙・脱ニコチン中毒製品市場収益:タイプ別
  • 世界の禁煙・脱ニコチン中毒製品市場収益:ニコチン代用療法別
    • ニコチンガム市場収益・分析
    • ニコチンパッチ市場収益・分析
    • ニコチンスプレー市場収益・分析
    • ニコチン吸入薬市場収益・分析
    • ニコチントローチ剤市場収益・分析
    • ニコチン舌下錠市場収益・分析
  • 世界の禁煙・脱ニコチン中毒製品市場収益:薬物療法別
    • ブプロピオン (Zyban) 市場収益・分析
    • バレニクリン (Champix, Chantix) 市場収益・分析
  • 世界の電子たばこ (eシガレット) 市場収益

第5章 禁煙・脱ニコチン中毒製品市場区分:地域別

  • 世界の禁煙・脱ニコチン中毒製品市場収益:地域別
  • 北米
    • タイプ別
    • 国別
  • 欧州
  • アジア太平洋州
  • その他の地域

第6章 企業プロファイル

  • Cipla Ltd.
  • GlaxoSmithKline plc
  • Imperial Tobacco Company of India Limited.
  • McNeil AB
  • NJOY, Inc.
  • Novartis International AG
  • Pfizer, Inc.
  • Revolymer PLC
  • 武田薬品工業

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban (bupropion), and Chantix/Champix (varenicline). Quitting smoking is also possible with or without assistance of healthcare professionals. The smoking cessation products market has been extensively analyzed on the basis of factors such as the products popularly used, success rate, and geographical reach.

The global smoking cessation and nicotine de-addiction market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the market. It also provides information and data analysis of the global smoking cessation and nicotine de-addiction market with respect to the segments based on the type of products, and their geographic analysis (by country). A detailed qualitative analysis of driving and restraining factors for the market growth and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global smoking cessation and nicotine de-addiction market.

Based on type of products, the smoking cessation and nicotine de-addiction market includes nicotine replacement therapy (NRT) products, drug therapy and e-cigarettes. The NRT products market is broadly segmented into nicotine containing gums, transdermal patches, lozenges, sublingual tablets, sprays and nasal inhalers. The prominently used brands for smoking cessation are Zyban and Chantix/Champix which comprise the drug therapy segment of the market. Geographically, the market is analyzed for four major regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW) The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.

A competitive landscape, mapping all the market players and their respective shares in the smoking cessation and nicotine de-addiction products market for 2012 are provided in this report. Some of the major players profiled for NRT products include Johnson & Johnson, GSK, Pfizer, Takeda Pharmaceuticals Co. Ltd., Cipla, and Revolymer PLC. GSK and Pfizer lead the market for drug therapy while the key players profiled for e-cigarettes market include VMR products, and NJOY. Each of these smoking cessation and nicotine de-addiction products market players are profiled in the report considering parameters such as company overview, financial overview, business strategies, product portfolio and recent developments.

The global smoking cessation and nicotine de-addiction products market has been segmented as follows:

Global Smoking Cessation and Nicotine De-Addiction Products Market, by Type

  • Nicotine Replacement Therapy Products
    • Nicotine Gums
    • Nicotine Transdermal Patches
    • Nicotine Lozenges
    • Nicotine Sprays
    • Nicotine Inhalers
    • Nicotine Subling ual Tablets
  • Drug Therapy
    • Zyban (bupropion)
    • Chantix/Champix (varenicline)
  • E-cigarettes

Global Smoking Cessation and Nicotine De-Addiction Products Market, by Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of Asia Pacific
  • Rest of the World (RoW)
    • Latin America (LATAM)
    • Middle East and North Africa (MENA)

Table of Contents

1. Preface

2. Executive Summary

  • 2.1. Introduction
  • 2.2. Global Smoking Cessation and Nicotine De-addiction Products Market: Market Snapshot
  • 2.3. Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography and Analysis

3. Industry Analysis: Smoking Cessation and Nicotine De-addiction Products Market

  • 3.1. Introduction and Market Definition
  • 3.2. Market Dynamics
    • 3.2.1. Drivers
      • 3.2.1.1. Rising awareness about smoking health hazards and smoking cessation therapy
      • 3.2.1.2. Introduction of new products
      • 3.2.1.3. Reimbursement for smoking cessation therapy
    • 3.2.2. Restraints
      • 3.2.2.1. Low awareness about smoking cessation products in developing economies
      • 3.2.2.2. Legal obligations dragging growth of several smoking cessation product segments
    • 3.2.3. Opportunity
      • 3.2.3.1. Research and development
      • 3.2.3.2. Market expansion in developing economies
  • 3.3. Market Attractiveness Analysis of Global Smoking Cessation and Nicotine De-addiction Products Market, by Geography
  • 3.4. Competitive Landscape: Heat Map Analysis

4. Smoking Cessation and Nicotine De-addiction Products Market Segmentation - by Type

  • 4.1. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn)
  • 4.2. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Nicotine Replacement Therapies, 2013-2023 (US$ Mn)
    • 4.2.1. Global Nicotine Gums Market Revenue, 2013-2023, (US$ Mn) and Analysis
    • 4.2.2. Global Nicotine Patches Market Revenue, 2013-2023, (US$ Mn) and Analysis
    • 4.2.3. Global Nicotine Sprays Market Revenue, 2013-2023, (US$ Mn) and Analysis
    • 4.2.4. Global Nicotine Inhalers Market Revenue, 2013-2023, (US$ Mn) and Analysis
    • 4.2.5. Global Nicotine Lozenges Market Revenue, 2013-2023, (US$ Mn) and Analysis
    • 4.2.6. Global Nicotine Sub lingual Tablets Market Revenue, 2013-2023, (US$ Mn) and Analysis
  • 4.3. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Drug Therapy, 2013-2023 (US$ Mn)
    • 4.3.1. Global Bupropione (Zyban) Market Revenue, 2013-2023, (US$ Mn) and Analysis
    • 4.3.2. Global Varenicline (Champix, Chantix) Market Revenue, 2013-2023, (US$ Mn)
  • 4.4. Global E- Cigarettes Market Revenue, 2013-2023, (US$ Mn)

5. Smoking Cessation and Nicotine De-addiction Products Market Segmentation - by Geography

  • 5.1. Global Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Geography, 2013-2023 (US$ Mn)
  • 5.2. North America
    • 5.2.1. North America Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn) and Analysis
    • 5.2.2. North America Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013-2023 (US$ Mn) and Analysis
  • 5.3. Europe
    • 5.3.1. Europe Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn) and Analysis
    • 5.3.2. Europe Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013-2023 (US$ Mn) and Analysis
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn) and Analysis
    • 5.4.2. Asia Pacific Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013-2023 (US$ Mn) and Analysis
  • 5.5. Rest of the World
    • 5.5.1. Rest of the World Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Type, 2013-2023 (US$ Mn) and Analysis
    • 5.5.2. Rest of the World Smoking Cessation and Nicotine De-addiction Products Market Revenue, by Country, 2013-2023 (US$ Mn) and Analysis

6. Company Profiles

  • 6.1. Cipla Ltd.
  • 6.2. GlaxoSmithKline plc
  • 6.3. Imperial Tobacco Company of India Limited.
  • 6.4. McNeil AB
  • 6.5. NJOY, Inc.
  • 6.6. Novartis International AG
  • 6.7. Pfizer, Inc.
  • 6.8. Revolymer PLC
  • 6.9. Takeda Pharmaceutical Co., Ltd.
Back to Top